Literature DB >> 6821806

Radiation therapy for primary lymphoma of bone.

D E Dosoretz, G F Murphy, A K Raymond, K P Doppke, A L Schiller, C C Wang, H D Suit.   

Abstract

The records of 30 patients with primary lymphoma of bone (PLB) who were treated with radiation therapy were reviewed. The probability of NED-survival and overall survival at five-year follow-up was 53 and 63%, respectively. There were three local failures following treatment. The cumulative incidence of local recurrence was 14% at five years. No local failures were observed when tumors received doses higher than 50 Gy, or equivalent to a TDF of 70 or greater. The number of failures was too small to examine for a correlation between histologic subclassification and local control frequency if doses higher than 50 Gy were utilized. Complications of treatment occurred in four patients. Functional results were excellent in all except two patients. These data provide guidelines for determination of a clinically appropriate radiation dose level for PLB.

Entities:  

Mesh:

Year:  1983        PMID: 6821806     DOI: 10.1002/1097-0142(19830101)51:1<44::aid-cncr2820510111>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Solitary skeletal lesions as primary manifestations of non-Hodgkin's lymphoma. Report of two cases and review of the literature.

Authors:  A G Schmidt; D Kohn; J Bernhards; S Braitinger
Journal:  Arch Orthop Trauma Surg       Date:  1994       Impact factor: 3.067

2.  Primary bone lymphoma: single institution case series.

Authors:  D G Power; G P McVey; G Korpanty; A Treacy; P Dervan; C O'Keane; D N Carney
Journal:  Ir J Med Sci       Date:  2008-05-31       Impact factor: 1.568

3.  Primary Bone Lymphoma: A 13 Year Retrospective Institutional Analysis in the Chemo-Immunotherapy Era.

Authors:  Archana Sharma; Rayaz Ahmed; Narendra Agrawal; Jyotsna Kapoor; Anurag Sharma; Vishvdeep Khushoo; Pragya Agrawal; Dinesh Bhurani; Sumeet P Mirgh
Journal:  Indian J Hematol Blood Transfus       Date:  2020-08-08       Impact factor: 0.900

4.  Localised lymphoma of bone: prognostic factors and treatment recommendations. The Princess Margaret Hospital Lymphoma Group.

Authors:  A J Rathmell; M K Gospodarowicz; S B Sutcliffe; R M Clark
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

5.  PRIMARY BONE LYMPHOMAS: RETROSPECTIVE ANALYSIS OF 42 CONSECUTIVE CASES.

Authors:  Telma Murias Dos Santos; Juan Pablo Zumárraga; Fábio Mazetti Reaes; Carlos Henrique Maçaneiro; André Mathias Baptista; Olavo Pires DE Camargo
Journal:  Acta Ortop Bras       Date:  2018 Mar-Apr       Impact factor: 0.513

6.  A Nomogram Predicting Overall and Cancer-Specific Survival of Patients with Primary Bone Lymphoma: A Large Population-Based Study.

Authors:  He-Hui Wang; Ke-Na Dai; A-Bing Li
Journal:  Biomed Res Int       Date:  2020-08-19       Impact factor: 3.411

7.  Are Higher Doses of Consolidation Radiation Therapy Necessary in Diffuse Large B-cell Lymphoma Involving Osseous Sites?

Authors:  Jessica W Lee; Leonard R Prosnitz; Alexandra Stefanovic; Chris R Kelsey
Journal:  Adv Radiat Oncol       Date:  2019-03-30

8.  Results of a Prospective Study of High-Dose or Conventional Anthracycline-Cyclophosphamide Regimen Plus Radiotherapy for Localized Adult Non-Hodgkin's Primary Bone Lymphoma.

Authors:  A Schmidt-Tanguy; R Houot; S Lissandre; J F Abgrall; P Casassus; P Rodon; B Desablens; J P Marolleau; R Garidi; T Lamy; M-P Moles-Moreau; G Damaj
Journal:  Adv Hematol       Date:  2014-03-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.